scholarly journals Systematic engineering of optimized autonomous heavy-chain variable domains

2021 ◽  
pp. 167241
Author(s):  
Johan Nilvebrant ◽  
June Ereño-Orbea ◽  
Maryna Gorelik ◽  
Mark C. Julian ◽  
Peter M. Tessier ◽  
...  
Keyword(s):  
2018 ◽  
Vol 19 (11) ◽  
pp. 3444 ◽  
Author(s):  
Hanna Wagner ◽  
Sarah Wehrle ◽  
Etienne Weiss ◽  
Marco Cavallari ◽  
Wilfried Weber

Nanobodies, the smallest possible antibody format, have become of considerable interest for biotechnological and immunotherapeutic applications. They show excellent robustness, are non-immunogenic in humans, and can easily be engineered and produced in prokaryotic hosts. Traditionally, nanobodies are selected from camelid immune libraries involving the maintenance and treatment of animals. Recent advances have involved the generation of nanobodies from naïve or synthetic libraries. However, such approaches demand large library sizes and sophisticated selection procedures. Here, we propose an alternative, two-step approach for the design and generation of nanobodies. In a first step, complementarity-determining regions (CDRs) are grafted from conventional antibody formats onto nanobody frameworks, generating weak antigen binders. In a second step, the weak binders serve as templates to design focused synthetic phage libraries for affinity maturation. We validated this approach by grafting toxin- and hapten-specific CDRs onto frameworks derived from variable domains of camelid heavy-chain-only antibodies (VHH). We then affinity matured the hapten binder via panning of a synthetic phage library. We suggest that this strategy can complement existing immune, naïve, and synthetic library based methods, requiring neither animal experiments, nor large libraries, nor sophisticated selection protocols.


2005 ◽  
Vol 98 (3) ◽  
pp. 905-910 ◽  
Author(s):  
Rachel Boxio ◽  
Christian Dournon ◽  
Jean-Pol Frippiat

A variety of immune parameters are modified during and after a spaceflight. The effects of spaceflights on cellular immunity are well documented; however, little is known about the effects of these flights on humoral immunity. During the Genesis space experiment, two adult Pleurodeles waltl (urodele amphibian) stayed 5 mo onboard Mir and were subjected to oral immunization. Animals were killed 10 days after their return to earth. IgM and IgY heavy-chain transcripts in their spleens were quantified by Northern blotting. The use of the different VH families (coding for antibody heavy-chain variable domains) in IgM heavy chain transcripts was also analyzed. Results were compared with those obtained with ground control animals and animals reared in classical conditions in our animal facilities. We observed that, 10 days after the return on earth, the level of IgM heavy-chain transcription was normal but the level of IgY heavy-chain transcription was at least three times higher than in control animals. We also observed that the use of the different VH families in IgM heavy-chain transcripts was modified by the flight. These data suggest that the spaceflight affected the antibody response against the antigens contained in the food.


Biochemistry ◽  
2000 ◽  
Vol 39 (6) ◽  
pp. 1217-1222 ◽  
Author(s):  
Silvia Spinelli ◽  
Leon G. J. Frenken ◽  
Pim Hermans ◽  
Theo Verrips ◽  
Kieron Brown ◽  
...  
Keyword(s):  

mAbs ◽  
2020 ◽  
Vol 12 (1) ◽  
pp. 1778435 ◽  
Author(s):  
Zehua Sun ◽  
Chuan Chen ◽  
Wei Li ◽  
David R. Martinez ◽  
Aleksandra Drelich ◽  
...  

2004 ◽  
Vol 48 (9) ◽  
pp. 3390-3395 ◽  
Author(s):  
A. Szynol ◽  
J. J. de Soet ◽  
E. Sieben-van Tuyl ◽  
J. W. Bos ◽  
L. G. Frenken

ABSTRACT Enzymes such as lactoperoxidase and glucose oxidase (GOx) are used as antimicrobial agents in oral care products. Their low specificities and substantiveness can be reduced by covalent coupling of antimicrobial molecules to antibodies. Variable domains (VHH) derived from llama heavy-chain antibodies are particularly suited for such an approach. The antibodies are composed solely of heavy-chain dimers; therefore, production of active fusion proteins by using molecular biology-based techniques is less complicated than production by use of conventional antibodies. In this study, a fusion protein consisting of VHH and GOx was constructed and expressed by Saccharomyces cerevisiae. A llama was immunized with Streptococcus mutans strain HG982. Subsequently, B lymphocytes were isolated and cDNA fragments encoding the VHH fragments were obtained by reverse transcription-PCR. After construction of a VHH library in Escherichia coli and screening of the library against mutans group streptococci and Streptococcus sanguinis strains, we found two VHH fragments with high specificities for S. mutans strains. A GOx gene was linked to the two VHH genes and cloned into S. cerevisiae yeasts. The yeasts expressed and secreted the recombinant proteins into the growth medium. The test of binding of fusion proteins to oral bacteria through their VHH fragments showed that S. mutans had been specifically targeted by GOx-S120, one of the fusion protein constructs. A low concentration of the fusion protein was also able to selectively kill S. mutans within 20 min in the presence of lactoperoxidase and potassium iodide. These findings demonstrate that the fusion protein GOx-VHH is potentially valuable in the selective killing of target bacteria such as S. mutans.


Antibodies ◽  
2018 ◽  
Vol 7 (3) ◽  
pp. 27 ◽  
Author(s):  
Lilach Vaks ◽  
Dana Litvak-Greenfeld ◽  
Stav Dror ◽  
Galia Matatov ◽  
Limor Nahary ◽  
...  

Bispecific antibodies (bsAbs) are antibodies with two binding sites directed at different antigens, enabling therapeutic strategies not achievable with conventional monoclonal antibodies (mAbs). Since bispecific antibodies are regarded as promising therapeutic agents, many different bispecific design modalities have been evaluated, but as many of them are small recombinant fragments, their utility could be limited. For some therapeutic applications, full-size IgGs may be the optimal format. Two challenges should be met to make bispecific IgGs; one is that each heavy chain will only pair with the heavy chain of the second specificity and that homodimerization be prevented. The second is that each heavy chain will only pair with the light chain of its own specificity and not with the light chain of the second specificity. The first solution to the first criterion (knobs into holes, KIH) was presented in 1996 by Paul Carter’s group from Genentech. Additional solutions were presented later on. However, until recently, out of >120 published bsAb formats, only a handful of solutions for the second criterion that make it possible to produce a bispecific IgG by a single expressing cell were suggested. We present a solution for the second challenge—correct pairing of heavy and light chains of bispecific IgGs; an engineered (artificial) disulfide bond between the antibodies’ variable domains that asymmetrically replaces the natural disulfide bond between CH1 and CL. We name antibodies produced according to this design “BIClonals”. Bispecific IgGs where the artificial disulfide bond is placed in the CH1-CL interface are also presented. Briefly, we found that an artificial disulfide bond between VH position 44 to VL position 100 provides for effective and correct H–L chain pairing while also preventing the formation of wrong H–L chain pairs. When the artificial disulfide bond links the CH1 with the CL domain, effective H–L chain pairing also occurs, but in some cases, wrong H–L pairing is not totally prevented. We conclude that H–L chain pairing seems to be driven by VH–VL interfacial interactions that differ between different antibodies, hence, there is no single optimal solution for effective and precise assembly of bispecific IgGs, making it necessary to carefully evaluate the optimal solution for each new antibody.


2002 ◽  
Vol 15 (5) ◽  
pp. 341-348 ◽  
Author(s):  
Denis C. Shaw ◽  
Brandon B. Shultz ◽  
Paul A. Ramsland ◽  
Allen B. Edmundson

2008 ◽  
Vol 377 (2) ◽  
pp. 478-488 ◽  
Author(s):  
Dirk Saerens ◽  
Katja Conrath ◽  
Jochen Govaert ◽  
Serge Muyldermans

Sign in / Sign up

Export Citation Format

Share Document